priavoid.com
  • Home
  • About us
    • Overview
    • Strategy
    • Management
    • Supervisory Board
    • Scientific Advisory Board
    • History
  • Drug Development
    • Therapeutic Focus
    • Technology
    • Pipeline
  • Investors and Media
    • News
    • Events
    • Partnering
    • Archive
  • Contact us
    • Careers
Seite wählen

Keystone Symposium

June 18th, 2019 – Keystone, CO, USA

Learn more

Dieter Willbold will present PRI-002 at the Keystone Symposium “Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2) in Keystone, CO, USA.

News & Events:

Office establishment

Office establishment

6. März 2020
BIO-EUROPE SPRING 2020

BIO-EUROPE SPRING 2020

3. März 2020
Seed Investment

Seed Investment

6. Mai 2019
CEOs of Priavoid

CEOs of Priavoid

3. Mai 2019
Prof. Willbold´s interview with PharmaVentures

Prof. Willbold´s interview with PharmaVentures

23. Januar 2018
Clinical trial with PRI-002

Clinical trial with PRI-002

31. Mai 2017
  • Home
  • Investors and Media
  • Legal Notice
  • Privacy Policy
  • Contact us
Copyright © 2019 Priavoid GmbH